D10Jhu81e Inhibitors
D10Jhu81e inhibitors are a class of compounds that specifically target a molecule or protein denoted by the code D10Jhu81e. While D10Jhu81e itself may not be widely referenced in standard biochemical literature, it is likely that it represents a unique protein, enzyme, or regulatory molecule within a specific cellular or biochemical pathway. Inhibitors of D10Jhu81e are designed to bind to and block the function of this target, altering its role within the biological system in which it operates. Such inhibition could impact its ability to interact with substrates, cofactors, or other molecules, leading to downstream effects on related processes such as signal transduction, metabolic regulation, or structural organization within the cell.
The mechanism of action of D10Jhu81e inhibitors likely involves their interaction with key structural or functional regions of the target protein. These inhibitors may be designed to fit into active sites or binding domains of D10Jhu81e, preventing it from carrying out its normal biological functions. Alternatively, they might bind allosterically, changing the protein's conformation in a way that reduces its activity. By disrupting the activity of D10Jhu81e, these inhibitors provide valuable insights into the molecular pathways in which this target operates. Understanding how inhibition of D10Jhu81e affects various cellular processes can shed light on the specific biological role of the molecule and its importance in maintaining cellular homeostasis or regulatory functions. These inhibitors are useful tools for probing the precise functions of D10Jhu81e within the context of its broader biological network.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMP-activated protein kinase (AMPK), leading to increased mitochondrial biogenesis and function. Gatd3a, located in the mitochondrion, may be indirectly influenced by AICAR through the activation of AMPK, affecting mitochondrial processes and potentially inhibiting Gatd3a activity. | ||||||
FCCP | 370-86-5 | sc-203578 sc-203578A | 10 mg 50 mg | $94.00 $355.00 | 46 | |
FCCP disrupts mitochondrial membrane potential, potentially impacting mitochondrial functions. Gatd3a, located in the mitochondrion, may be indirectly inhibited by FCCP through disturbance of mitochondrial homeostasis, affecting processes linked to Gatd3a activity. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
Rotenone inhibits complex I of the electron transport chain (ETC), impacting mitochondrial function. Gatd3a, situated in the mitochondrion, may be indirectly affected by Rotenone through disruption of ETC, influencing mitochondrial processes and potentially inhibiting Gatd3a activity. | ||||||
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $149.00 $12495.00 | 18 | |
Oligomycin inhibits ATP synthase, affecting mitochondrial ATP production. Gatd3a, located in the mitochondrion, may be indirectly inhibited by Oligomycin through interference with ATP synthesis, impacting mitochondrial processes associated with Gatd3a activity. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-DG inhibits glycolysis by blocking glucose metabolism. Gatd3a, located in the mitochondrion, may be indirectly influenced by 2-DG through metabolic alterations, affecting mitochondrial processes and potentially inhibiting Gatd3a activity. | ||||||
Bongkrekic acid | 11076-19-0 | sc-205606 | 100 µg | $400.00 | 10 | |
Bongkrekic acid inhibits the adenine nucleotide translocator, affecting mitochondrial ATP transport. Gatd3a, located in the mitochondrion, may be indirectly influenced by Bongkrekic acid through interference with ATP transport, impacting mitochondrial processes associated with Gatd3a activity. | ||||||
UK 5099 | 56396-35-1 | sc-361394 sc-361394A | 10 mg 50 mg | $236.00 $987.00 | 5 | |
UK5099 inhibits mitochondrial pyruvate carrier (MPC), affecting pyruvate transport into mitochondria. Gatd3a, located in the mitochondrion, may be indirectly inhibited by UK5099 through interference with pyruvate transport, influencing mitochondrial processes linked to Gatd3a activity. | ||||||
(+)-Etomoxir sodium salt | 828934-41-4 | sc-215009 sc-215009A | 5 mg 25 mg | $151.00 $506.00 | 3 | |
Etomoxir inhibits carnitine palmitoyltransferase 1 (CPT-1), impacting fatty acid oxidation. Gatd3a, located in the mitochondrion, may be indirectly affected by Etomoxir through interference with fatty acid metabolism, influencing mitochondrial processes associated with Gatd3a activity. | ||||||
3-Nitropropionic acid | 504-88-1 | sc-214148 sc-214148A | 1 g 10 g | $82.00 $459.00 | ||
3-NPA inhibits succinate dehydrogenase, disrupting the TCA cycle. Gatd3a, located in the mitochondrion, may be indirectly inhibited by 3-NPA through interference with the TCA cycle, affecting mitochondrial processes associated with Gatd3a activity. | ||||||